Evaluating measurable residual disease in acute myeloid leukemia
Abstract: Mounting evidence indicates that the presence of measurable (“minimal”) residual disease (MRD), defined as posttherapy persistence of leukemic cells at levels below morphologic detection, is a strong, independent prognostic marker of increased risk of relapse and shorter survival in patien...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2018-06-01
|
| Serie: | Blood Advances |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2473952920309976 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|